Info@ThinkPinkRocks.com

Guinea Phase III trial shows VSV-EBOV vaccine highly effective against Ebola

Results from an interim analysis of the Guinea Phase III efficacy vaccine trial show that VSV-EBOV (Merck, Sharp & Dohme) is highly effective against Ebola.

See more here:
Guinea Phase III trial shows VSV-EBOV vaccine highly effective against Ebola

Share

Leave a Reply